↓ Skip to main content

Two open-label, single arm, non-randomized phase II studies of irinotecan for the treatment of metastatic breast cancer in patients with increased copy number of the topoisomerase I gene

Overview of attention for article published in BMC Cancer, June 2019
Altmetric Badge

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
23 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Two open-label, single arm, non-randomized phase II studies of irinotecan for the treatment of metastatic breast cancer in patients with increased copy number of the topoisomerase I gene
Published in
BMC Cancer, June 2019
DOI 10.1186/s12885-019-5788-9
Pubmed ID
Authors

Iben Kümler, Eva Balslev, Jan Stenvang, Nils Brünner, Bent Ejlertsen, Erik Hugger Jakobsen, Dorte Lisbet Nielsen

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 23 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 17%
Student > Bachelor 3 13%
Lecturer 2 9%
Student > Master 2 9%
Other 1 4%
Other 4 17%
Unknown 7 30%
Readers by discipline Count As %
Medicine and Dentistry 6 26%
Pharmacology, Toxicology and Pharmaceutical Science 3 13%
Biochemistry, Genetics and Molecular Biology 2 9%
Unspecified 1 4%
Economics, Econometrics and Finance 1 4%
Other 1 4%
Unknown 9 39%